Latest Insider Transactions at Bright Health Group Inc. (BHG)
This section provides a real-time view of insider transactions for Bright Health Group Inc. (BHG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bright Health Group Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bright Health Group Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 06
2025
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,970
-21.88%
|
$34,790
$7.33 P/Share
|
|
Jan 06
2025
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
2,486
-24.75%
|
$17,402
$7.33 P/Share
|
|
Jan 06
2025
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,368
-18.71%
|
$9,576
$7.33 P/Share
|
|
Jan 06
2025
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
31,798
-17.83%
|
$222,586
$7.33 P/Share
|
|
Jan 06
2025
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
1,233
-13.6%
|
$8,631
$7.33 P/Share
|
|
Jan 03
2025
|
George Lawrence Mikan Iii CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
95,308
+34.83%
|
-
|
|
Jan 03
2025
|
Tomas Orozco EVP, Consumer Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,971
+30.47%
|
-
|
|
Jan 03
2025
|
Jay Matushak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,237
+36.82%
|
-
|
|
Jan 03
2025
|
Jeffery Michael Craig GC & Corporate Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,618
+39.72%
|
-
|
|
Jan 03
2025
|
Jeffrey J Scherman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,640
+33.24%
|
-
|
|
Dec 17
2024
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
16,803
-16.83%
|
$67,212
$4.18 P/Share
|
|
Dec 14
2024
|
George Lawrence Mikan Iii CEO & President |
BUY
Exercise of conversion of derivative security
|
Direct |
35,000
+25.96%
|
-
|
|
Oct 07
2024
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
87
-0.91%
|
$435
$5.18 P/Share
|
|
Oct 04
2024
|
Jay Matushak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
263
+2.68%
|
-
|
|
May 12
2024
|
Jeffrey R Immelt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+26.16%
|
-
|
|
May 12
2024
|
Manuel Kadre Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+19.75%
|
-
|
|
May 12
2024
|
Stephen Kraus Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+44.44%
|
-
|
|
May 12
2024
|
Matthew G Manders Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+43.24%
|
-
|
|
May 12
2024
|
Robert J Sheehy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+50.0%
|
-
|
|
May 12
2024
|
Mohamad Makhzoumi |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+44.45%
|
-
|
|
May 12
2024
|
Linda R Gooden Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+4.55%
|
-
|
|
May 12
2024
|
Kedrick D Adkins Jr Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+4.55%
|
-
|
|
May 12
2024
|
Andrew M Slavitt Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,755
+37.19%
|
-
|
|
May 10
2024
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
113
-2.99%
|
$678
$6.05 P/Share
|
|
May 10
2024
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
317
-3.29%
|
$1,902
$6.05 P/Share
|
|
May 09
2024
|
Jeffrey J Scherman Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
343
+8.31%
|
-
|
|
May 09
2024
|
Jay Matushak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
978
+9.23%
|
-
|
|
Mar 18
2024
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
568
-14.17%
|
$3,976
$7.27 P/Share
|
|
Mar 18
2024
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,083
-11.14%
|
$7,581
$7.27 P/Share
|
|
Mar 18
2024
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
260
-7.05%
|
$1,820
$7.27 P/Share
|
|
Mar 18
2024
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
822
-13.9%
|
$5,754
$7.27 P/Share
|
|
Mar 18
2024
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
4,990
-7.15%
|
$34,930
$7.27 P/Share
|
|
Mar 15
2024
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
151
-3.94%
|
$1,057
$7.1 P/Share
|
|
Mar 15
2024
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
79
-1.32%
|
$553
$7.1 P/Share
|
|
Mar 15
2024
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
98
-2.39%
|
$686
$7.1 P/Share
|
|
Mar 15
2024
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
3,442
-4.7%
|
$24,094
$7.1 P/Share
|
|
Mar 15
2024
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
248
-2.49%
|
$1,736
$7.1 P/Share
|
|
Mar 14
2024
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
105
-2.66%
|
$735
$7.06 P/Share
|
|
Mar 14
2024
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
54
-0.89%
|
$378
$7.06 P/Share
|
|
Mar 14
2024
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
68
-1.63%
|
$476
$7.06 P/Share
|
|
Mar 14
2024
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
2,398
-3.17%
|
$16,786
$7.06 P/Share
|
|
Mar 14
2024
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
173
-1.7%
|
$1,211
$7.06 P/Share
|
|
Mar 13
2024
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
99
-2.32%
|
$693
$7.3 P/Share
|
|
Mar 13
2024
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
78
-1.27%
|
$546
$7.3 P/Share
|
|
Mar 13
2024
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
152
-3.71%
|
$1,064
$7.3 P/Share
|
|
Mar 13
2024
|
George Lawrence Mikan Iii CEO & President |
SELL
Open market or private sale
|
Direct |
3,463
-4.38%
|
$24,241
$7.3 P/Share
|
|
Mar 13
2024
|
Jay Matushak Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
251
-2.41%
|
$1,757
$7.3 P/Share
|
|
Mar 12
2024
|
Jeffrey J Scherman Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
45
-1.04%
|
$315
$7.76 P/Share
|
|
Mar 12
2024
|
Tomas Orozco EVP, Consumer Care |
SELL
Open market or private sale
|
Direct |
36
-0.58%
|
$252
$7.76 P/Share
|
|
Mar 12
2024
|
Jeffery Michael Craig GC & Corporate Secretary |
SELL
Open market or private sale
|
Direct |
70
-1.68%
|
$490
$7.76 P/Share
|